BioElectronics Corporation (BIEL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -335.99 Thousand | -478.6 Thousand | -320.29 Thousand | -528.03 Thousand | -715.68 Thousand | -1.35 Million |
| Net Income | -722.81 Thousand | -784.91 Thousand | -289.82 Thousand | -1.15 Million | -2.32 Million | -2.98 Million |
| Depreciation & Amortization | - | - | - | - | 829.00 | 2210.00 |
| Deferred income taxes | - | - | - | - | 876.09 Thousand | - |
| Stock-based compensation | - | - | 6.50 | 160.59 | 3.87 | 204.72 |
| Change in working capital | -111.41 Thousand | -64.67 Thousand | -279.42 Thousand | 215.9 Thousand | 649.85 Thousand | 539.66 Thousand |
| Other non-cash items | 564.97 Thousand | 594.17 Thousand | 85.19 Thousand | 444.74 Thousand | 82.81 Thousand | 1.06 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 295.63 Thousand | 522.71 Thousand | 211.61 Thousand | 591.45 Thousand | 668.97 Thousand | 1.43 Million |
| Debt repayment | -295.63 Thousand | -522.71 Thousand | -211.61 Thousand | -591.45 Thousand | -668.97 Thousand | -1.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -112.47 | -131.69 | - | -44.14 Thousand |
| Accounts receivables | -72.22 Thousand | -20.84 Thousand | 105.19 Thousand | 9501.00 | -179.99 Thousand | -121.8 Thousand |
| Accounts payables | -80.07 Thousand | -101 Thousand | -67.89 Thousand | 13.98 Thousand | 862.02 Thousand | 4992.00 |
| Inventory | 85.55 Thousand | -101.34 Thousand | 126.45 Thousand | -52.45 Thousand | 195.72 Thousand | 146.22 Thousand |
| Other working capital | -44.66 Thousand | 158.51 Thousand | -443.17 Thousand | 244.87 Thousand | -227.89 Thousand | 510.25 Thousand |
| Cash at beginning of period | 45.03 Thousand | 925.00 | 109.61 Thousand | 46.19 Thousand | 92.9 Thousand | 8894.00 |
| Cash at end of period | 4686.00 | 45.03 Thousand | 925.00 | 109.61 Thousand | 46.19 Thousand | 92.9 Thousand |
| Capital Expenditure | 1.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -40.35 Thousand | 44.11 Thousand | -108.68 Thousand | 63.41 Thousand | -46.71 Thousand | 84.01 Thousand |
| Free Cash Flow | -335.99 Thousand | -478.6 Thousand | -320.29 Thousand | -528.03 Thousand | -715.68 Thousand | -1.35 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -722.81 Thousand | - | - | -209.35 Thousand | -784.91 Thousand | -226.96 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -111.41 Thousand | - | - | 26.34 Thousand | -64.67 Thousand | -104.62 Thousand |
| Other non-cash items | 564.97 Thousand | - | - | 87.66 Thousand | 594.17 Thousand | 216 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 295.63 Thousand | - | - | 25.86 Thousand | 522.71 Thousand | 250.07 Thousand |
| Debt repayment | -295.63 Thousand | - | - | -25.86 Thousand | -522.71 Thousand | -250.07 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -72.22 Thousand | - | - | -500.00 | -20.84 Thousand | -11.71 Thousand |
| Accounts payables | -80.07 Thousand | - | - | -2832.00 | -101 Thousand | -59.62 Thousand |
| Inventory | 85.55 Thousand | - | - | 34.64 Thousand | -101.34 Thousand | -24.14 Thousand |
| Other working capital | -44.66 Thousand | - | - | -4970.00 | 158.51 Thousand | -9145.00 |
| Cash at beginning of period | 45.03 Thousand | - | 6871.00 | 45.03 Thousand | 925.00 | 6026.00 |
| Cash at end of period | 4686.00 | - | 6871.00 | 6871.00 | 45.03 Thousand | 45.03 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -40.35 Thousand | - | - | -38.16 Thousand | 44.11 Thousand | 39.01 Thousand |
| Free Cash Flow | -335.99 Thousand | - | - | -64.02 Thousand | -478.6 Thousand | -211.06 Thousand |
6855
ITP
8279
GTBT
DOCMF
AXISBANK